Cost Conscious Care Ashley Duckett, MD Medical University of South Carolina June 25, 2013.

Slides:



Advertisements
Similar presentations
Improving outcomes for older people: Monitoring and regulating standards Ann Close 8 th June 2011.
Advertisements

Disease State Management The Pharmacist’s Role
Interviewing Techniques as Tools for Diagnosis and Treatment, part 3 The Helpful Interview The Practice of Medicine -1 Christine M. Peterson, M.D.
Drug Utilization Review (DUR)
Basma Y. Kentab MSc. Department of Clinical Pharmacy May 2014.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
Economic Analysis and Management Todd Wagner, PhD.
Informatics And The New Healthcare System Information Technology Will Provide the Platform for Quality Improvement in Healthcare for the 21 st Century.
WA ACEP November Disclaimers Introduction – Choosing Wisely Campaign II 2014 ACEP Recommendations – Avoid: CT scan of the head for asymptomatic.
ABCWINRisk and Statistics1 Risk and Statistics Risk Assessment in Clinical Decision Making Ulrich Mansmann Medical Statistics Branch University of Heidelberg.
Defining and Maintaining Core David Taylor. In the UK there is little flexibility The GMC have produced two documents The GMC have produced two documents.
BS Evidence Based Medicine And Atrial Fibrillation.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Clinical Pharmacy Basma Y. Kentab MSc..
Indianapolis Discovery Network for Dementia Translating PREVENT Into Your Practice Caring for your patients with dementia J. Eugene Lammers, MD, MPH Clarian.
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.5: Unit 5: Financing Health Care (Part 2) 1.5d: Controlling Medical Expenses.
Caring for Older Adults Holistically, 4th Edition Chapter Five Promoting Wellness.
Consent for Research Study RESCUE: Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic Examinations ACRIN
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Quality in Laboratory Medicine Conference Business Case for Quality Recognizing Excellence in Practice Presented to the Institute for Quality in Laboratory.
Becoming an Activated Patient – Part 2
Pay-for-Performance: A Decision Guide for Purchasers Guide Prepared for: Agency for HealthCare Research and Quality U.S. Department of Health and Human.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Medication Adherence The following module is designed as a basic overview of medication adherence for providers of healthcare, particularly those in a.
Client Centred Practice and Management of Risk Falls Prevention Forum for People with Dementia in Gippsland Monday 15 th September 2014 Nicole Tierney.
Cost Containment and QALYsQALY 1. What’s a “good” buy? “Expensive” more than $100,000/QALY “Reasonable” $50,000/QALY (UK upper limit ~ $47,000) “Very.
Performance Measurement Sets Dolores Yanagihara Program Development Manager IHA.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Dr K N Prasad Community Medicine
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
Pay-for-Performance: A Decision Guide for Purchasers Guide Prepared for: Agency for HealthCare Research and Quality U.S. Department of Health and Human.
What the College is doing for you & High Value Care Robert H. Lohr, MD, FACP Board of Regents American College of Physicians.
November 5, 2014 Matthew Tuck, MD Hospitalist, Veterans Affairs Medical Center Assistant Professor of Medicine, George Washington University.
ACOVE 2: Falls and Mobility. Falls Pretest Question 1 n = 67.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Managing Exercise in Persons with Multiple Chronic Conditions Chapter 04.
Cost-effectiveness of Screening Tests Mark Hlatky, MD Stanford University.
Improving Value in Health Care: Challenges and Potential Strategies Arnold M Epstein October 24, 2008 Congressional Health Care Reform Education Project.
Introduction.
Some reasons for unnecessary procedures
Justification of Medical Imaging WHO's perspective Dr Maria del Rosario Pérez Department of Public Health, Environmental and Social Determinants of Health.
Jan 2002 EDMA The central role of the Medical Laboratory in a World of Managed Health An EDMA presentation of the benefits of in vitro testing as a basis.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
Utilizing Biostatistics in Diagnosis, Screening, and Prevention Presentation 3 of 6.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
High Value Quality Improvement Presentation 6 of 6.
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Medical Necessity Criteria An Overview of Key Components Presented by BHM Healthcare Solutions.
High Value Quality Improvement Fellowship HVC Curriculum Presentation 7 of 7.
Choosing Wisely Or Five Ways To Save A Quick $7 Billion J. Paul Martin, MD Ann Marie Padilla, MD Alan Thomas, MD.
More care is not necessarily better care An initiative of the Council of Medical Colleges in New Zealand.
Clinical Quality Improvement: Achieving BP Control
Choosing Wisely Pharmacy’s Role and Recommendations Mary Wong
Background Methods Results Discussion Conclusion
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
M. Lee Chambliss MD MSPH Associate Professor
Prescribing.
Rural Chest Pain Quality Improvement
Opioid Prescribing & Monitoring
NAPLEX preparation: Biostatistics
Developing a Health Maintenance Schedule
Cultural Diversity in Health Care
Reducing Unnecessary Testing & Hospitalizations
Chapter 33 Acute Care.
Pharmacy practice and the healthcare system Ola Ali Nassr
CPOE Medication errors resulting in preventable ADEs most commonly occur at the prescribing stage. Bobb A, et al. The epidemiology of prescribing errors:
Nutrition Interventions to Improve Quality of Care
Presentation transcript:

Cost Conscious Care Ashley Duckett, MD Medical University of South Carolina June 25, 2013

Objectives Understand principles of cost conscious care Recognize barriers to cost conscious care Identify available resources for learning about and teaching cost conscious care

High Costs of Health Care Health care is expensive – New tests, drugs, procedures, devices are primary drivers of increased costs – 30% of healthcare costs are wasted costs – 10% of population accounts for 65% of costs Goal is improved quality, decreased cost – Current system rewards doing more tests – Few physicians intentionally abuse system, but all contribute – ACOs should align incentives with quality – Measuring underuse of high value services (ie preventive services, meds for chronic problems) and overuse of low value services (imaging for low back pain)

Costs of Labs Physicians have poor understanding of costs – Costs include downstream costs of unintended consequences – Estimates online at or Cost is not the same as value – Low cost interventions may have little value and high cost interventions may have good value Least experienced physicians have most control over ordering of lab tests in inpatient setting Little understanding of comparative utilization and practice patterns – Residents need to get feedback on their ordering patterns, particularly in comparison to others on the same service

Reporting Milestones

Cost-Effectiveness of Selected Preventive Measures and Treatments Cost effectiveness= Incremental costs / Incremental health benefits (in terms of QALY’s), relative to a comparator (no treatment or current treatment). Cohen J, Neumann P, Weinstein M NEJM 2008:358;7 Cost effectiveness threshold of $50,000-$100,000 per QALY has historically been considered acceptable QALYs are not used at the direct patient care level, but may help understand the balance between benefits, risks/harms, and costs associated with medical interventions Intervention Cost-Effectiveness Ratio H flu vaccination of toddlersCost-saving One time colonoscopy screening for CA in men 60-64Cost-saving Screening all 65 y/o for DM (compared with those with HTN) $590,000/ QALY HAART for HIV $29,000/QALY Defibrillators $52,000/QALY

Choosing Wisely ABIM campaign to spark dialogue about waste in healthcare system – Promote care that is necessary, free from harm, not duplicative and supported by evidence 5 things Physicians and Patients Should Question Patient friendly resources from Consumer Reports – Chronic Kidney Disease: Making Hard Choices – Cancer Care at the End of Life: When to Choose Supportive Care

Choosing Wisely – SHM Adult Hospitalist “Avoid List” 1.No foley catheters for convenience, incontinence or monitoring uop 2.No stress ulcer prophylaxis unless high risk 3.No blood transfusions in absence of symptoms (or active ACS, CHF, or stroke) 4.No telemetry outside of ICU without a protocol 5.No repeat CBC, BMP in setting of lab stability

Choosing Wisely – ACP “Avoid list” 1. No screening exercise electrocardiogram testing in individuals who are asymptomatic and at low risk (<10% 10 year risk) for coronary heart disease. 2. No imaging studies in patients with non-specific low back pain. 3. In the evaluation of simple syncope and a normal neurological examination, don’t obtain brain imaging studies (CT or MRI). 4. In patients with low risk for VTE order D-dimer instead of imaging as first test. 5. No preoperative chest radiography in the absence of a clinical suspicion for intrathoracic pathology.

Choosing Wisely – American Geriatrics Society “Avoid List” 1. Don’t recommend PEG tubes in patients with advanced dementia; instead offer oral assisted feeding. 2. Don’t use antipsychotics as first choice to treat behavioral and psychological symptoms of dementia. 3. Avoid using medications to achieve hemoglobin A1c <7.5% in most adults age 65 and older; moderate control is generally better. 4. Don’t use benzodiazepines or other sedative-hypnotics in older adults as first choice for insomnia, agitation or delirium. 5. Don’t use antimicrobials to treat bacteriuria in older adults unless specific urinary tract symptoms are present.

ACP/AAIM Curriculum 10 modules, PP presentations, facilitators guides 1.Introduction to Healthcare Value 2.Healthcare Waste, Costs, and Over-Ordering of Tests 3.Health Insurance 4. Healthcare Costs and Payment Models 5.Biostatistical Concepts You Need to Know 6.Screening and Prevention 7.Balancing Benefits with Harms and Costs 8.High Value Medication Prescribing 9.Barriers to High Value, Cost Conscious Care 10.Local QI Project

Steps Toward High-Value Cost- Conscious Care Step 1: Understand the benefits, harms, and relative costs of the interventions that you are considering Step 2: Decrease or eliminate the use of interventions that provide no benefits and/or may be harmful Step 3: Choose interventions and care settings that maximize benefits, minimize harms, and reduce costs (using comparative effectiveness and cost-effectiveness data) Step 4: Customize a care plan with the patient that incorporates their values and addresses their concerns Step 5: Identify system level opportunities to improve outcomes, minimize harms, and reduce healthcare waste ACP website

Reasons Residents Over Order Tests 1.Duplicating role modeled behavior 2.Desire to be complete 3.Pre-emptive ordering/rushing an evaluation/unnecessary duplication of tests 4.Discomfort with Diagnostic Uncertainty 5.Curiosity 6.Lack of knowledge of the costs and harms 7.Defensive medicine 8.Patient requests 9.Faculty demand 10.No training in weighing benefit relative to cost and harm 11.Ease of access to services when patient is hospitalized

Questions to ask before ordering tests Did the patient have this test previously? Will the result of this test change the care of the patient? What are the probability and potential adverse consequences of a false positive result? Is the patient in potential danger in the short term if I do not perform this test? Am I ordering the test primarily because the patient wants it or to reassure the patient?

Stats You Can Use Likelihood ratios – How to use a test to change your confidence – Calculated from sensitivity and specificity – Can be applied to physical exam findings as well as lab tests and imaging Pretest probability Odds ratios (case-control), relative risks (RCTs and cohort studies) Relative Risk Reduction, Absolute Risk Reduction, number needed to treat (NNT) and number needed to hard (NNH)

Role of History and Physical Exam History and physical exam are very cost-conscious and can be high value – Inpt and outpt studies show most dx made on H&P alone Physicians lack confidence in physical exam Undervalue physical exam, especially negative findings – In the presence of important physical findings (those with high LR’s) we order more tests, even though there is a high probability of a disease being present – With negative clinically relevant physical exam findings we are even more likely to order extra tests Need to understand clinical utility of history and physical exam findings and apply to patient care – Rational Clinical Exam series in JAMA, lit searches

High Value Medication Use 1.Is prescription medication absolutely necessary? Know when drugs are indicated. Stop any medications that are not indicated. Don’t be afraid to try lifestyle modifications or over the counter medications in lieu of prescriptions. 2.Which medications should I prescribe? For insured patients, try to find equivalent medications on their formularies. “CR” and “ER” preparations and combo drugs tend to be more expensive. 3.Should I use generic vs. brand name? MOST (not all) drugs can be safely switched to generics. Generics are 1/4 to 1/10 of the cost. Evaluate affordability before prescribing new medications to patients

Defensive Medicine Very common barrier to cost-effective care Leads to overutilization Doesn’t protect against malpractice Malpractice claims can be arbitrary and hard to prevent: 40% do not involve medical errors More care is not better care -- tests and treatments have harms associated with them Lack of follow up of abnormal test results often leads to malpractice litigation- don’t order the test if you don’t plan on following it up and acting on the results Tips: listen to your patients and carefully document decision making including discussion of side effects and risks of all tests and treatments

Key Messages Be aware of tests and treatments that are not considered to be high value or cost conscious Consider costs and value when ordering new medications and diagnostic testing

References Baker et al. Baker et al. Design and Use of Performance Measures to Decrease Low-Value Services and Achieve Cost-Conscious Care. Ann Intern Med. 2013;158(1): Dine et al. Dine et al. Educating Physicians in Training About Resource Utilization and Their Own Outcomes of Care in the Inpatient Setting. Journal of GME. 2010; 2(2); Herrle et al. Herrle et al. Bayes Theorem and the Physical Examination: Probability Assessment and Diagnostic Decision Making. Academic Medicine. 2011; 86 (5): Qaseem et al. Qaseem et al. Appropriate Use of Screening and Diagnostic Tests to Foster High-Value, Cost-Conscious Care. Ann Int Med. 2012; 156 (2): choosingwisely.org hvc.acponline.org